Agios Pharmaceuticals AGIO Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $66.05M+78.3% | $54.03M+48.0% | $44.79M+36.3% | $40.88M+30.6% | $37.04M+26.0% | ||
| $6.58M+42.3% | $6.35M+52.3% | $5.73M+64.0% | $4.83M+44.6% | $4.62M+56.5% | ||
| $59.47M+83.5% | $47.68M+47.5% | $39.07M+33.0% | $36.05M+28.9% | $32.41M+22.5% | ||
| 90%+2.5pp | 88.3%-0.3pp | 87.2%-2.2pp | 88.2%-1.1pp | 87.5%-2.4pp | ||
| $347.94M+13.9% | $339.54M+12.7% | $334.29M+12.9% | $319.95M+4.8% | $305.41M+2.9% | ||
| $187.06M+11.8% | $180.28M+15.0% | $180.37M+28.5% | $177.63M+39.1% | $167.3M+36.5% | ||
| $541.58M+13.5% | $526.16M+13.8% | $520.38M+18.3% | $502.41M+15.1% | $477.33M+13.0% | ||
| -$475.53M-8.0% | -$472.13M-10.9% | -$475.59M-16.9% | -$461.53M-13.9% | -$440.29M-12.0% | ||
| -720%+469pp | -873.9%+293pp | -1,061.8%+176pp | -1,129.1%+165pp | -1,188.9%+148pp | ||
| $51.09M-7.6% | $56.38M+17.3% | $61.98M+60.2% | $61.67M+81.4% | $55.28M+61.9% | ||
| $822K-86.5% | $1.96M-69.8% | $3.47M-47.3% | $5.05M-17.5% | $6.11M-1.3% | ||
| -$422.6M— | -$412.78M— | —— | —— | —— | ||
| -639.8%— | -764%— | —— | —— | —— | ||
| -$7.25— | -$7.11— | —— | —— | —— | ||
| -$470.27M-8.2% | -$466.96M-11.2% | -$470.31M-17.2% | -$456.28M-14.3% | -$434.71M-12.4% | ||
| -712%+462pp | -864.3%+287pp | -1,050%+171pp | -1,116.3%+159pp | -1,173.8%+142pp | ||
| -$475.53M-8.0% | -$472.13M-10.9% | -$475.59M-16.9% | -$461.53M-13.9% | -$440.29M-12.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Agios Pharmaceuticals's revenue?
- Agios Pharmaceuticals (AGIO) generated $66.0M in revenue over the trailing twelve months, up 78.3% year over year.
- Is Agios Pharmaceuticals profitable?
- Agios Pharmaceuticals is not currently profitable: it reported a net loss of $422.6M over the trailing twelve months, a -639.8% net margin.
- What are Agios Pharmaceuticals's profit margins?
- Gross margin is 90.0% and operating margin is -720.0%, with a -639.8% net margin.
- What is Agios Pharmaceuticals's earnings per share?
- Agios Pharmaceuticals's diluted EPS over the trailing twelve months is $-7.25.
- Where does Agios Pharmaceuticals's income statement data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
